Extended Use of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 1 Diabetes: 12-Month Extension of a Randomized Controlled Trial.

Endocrinol Diabetes MetabSep 1, 2026
Clinical ResearchEndocrinologyOpen access

Eric Renard, Ruth S Weinstock, Alfred Penfornis et al.

✦ AI-curated · Sources linked

In 30 seconds

This 12-month extension of a randomized controlled trial evaluated the Omnipod 5 Automated Insulin Delivery System in 75 adults with Type 1 diabetes. Results showed a significant increase in time in range (70-180 mg/dL) by 17.9% and a decrease in HbA1c from 8.33% to 7.18%, indicating sustained glycemic control and safety.

Key findings

  • Time in range (70-180 mg/dL) increased by 17.9% to 62.3%.
  • HbA1c decreased from 8.33% to 7.18% (-1.14%).
  • Time above range (>180 mg/dL) decreased by 17.7%.
  • Adverse events were infrequent at 12 per 100 person-years.

Why it matters

The study provides evidence that the Omnipod 5 AID system can sustain glycemic control and improve quality of life in adults with Type 1 diabetes, which is crucial for long-term diabetes management.

Source

PubMed · PMID 42671087Free full text on PubMed Central

Published in Endocrinol Diabetes Metab. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Endocrinology

Clinical ResearchOncology (Medical)

Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.

This phase 3 randomized clinical trial evaluated the efficacy and safety of osimertinib combined with chemotherapy versus osimertinib alone in 294 patients with advanced non-small cell lung cancer (NSCLC) harboring…

JAMASep 8, 2026Open accessRead summary
Clinical ResearchHematology

Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.

This phase 2 randomized trial compared azacitidine plus venetoclax to induction chemotherapy in 172 previously untreated adults with acute myeloid leukemia (AML) eligible for induction.

N Engl J MedSep 3, 2026Read summary
Clinical ResearchPsychiatry

The efficacy of modified psychodynamic psychotherapy for patients with schizophrenia-spectrum disorders in Germany: a prospective, single-centre, assessor-blinded, parallel-group, randomised controlled trial.

This randomized controlled trial evaluated the efficacy of Modified Psychodynamic Psychotherapy for Schizophrenia (MPP-S) combined with treatment as usual (TAU) in 130 outpatients with schizophrenia-spectrum disorders…

Lancet PsychiatrySep 10, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.